The Safety and Efficacy of Live Viral Vaccines in Patients With Cartilage-Hair Hypoplasia

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2020 Aug 28

PMID 32849667

Citations 4

Authors

Svetlana Vakkilainen

Iivari Kleino

Jarno Honkanen

Harri Salo

Leena Kainulainen

Michaela Grasbeck

Eliisa Kekalainen

Outi Makitie

Paula Klemetti

Affiliations

Soon will be listed here.

Abstract

Background: Live viral vaccines are generally contraindicated in patients with combined immunodeficiency including cartilage-hair hypoplasia (CHH); however, they may be tolerated in milder syndromes. We evaluated the safety and efficacy of live viral vaccines in patients with CHH.

Methods: We analyzed hospital and immunization records of 104 patients with CHH and measured serum antibodies to measles, mumps, rubella, and varicella zoster virus (VZV) in all patients who agreed to blood sampling ( = 50). We conducted a clinical trial (ClinicalTrials.gov identifier: NCT02383797) of live VZV vaccine on five subjects with CHH who lacked varicella history, had no clinical symptoms of immunodeficiency, and were seronegative for VZV; humoral and cellular immunologic responses were assessed post-immunization.

Results: A large proportion of patients have been immunized with live viral vaccines, including measles-mumps-rubella (MMR) ( = 40, 38%) and VZV ( = 10, 10%) vaccines, with no serious adverse events. Of the 50 patients tested for antibodies, previous immunization has been documented with MMR ( = 22), rubella ( = 2) and measles ( = 1) vaccines. Patients with CHH demonstrated seropositivity rates of 96%/75%/91% to measles, mumps and rubella, respectively, measured at a medium of 24 years post-immunization. Clinical trial participants developed humoral and cellular responses to VZV vaccine. One trial participant developed post-immunization rash and knee swelling, both resolved without treatment.

Conclusion: No serious adverse events have been recorded after immunization with live viral vaccines in Finnish patients with CHH. Patients generate humoral and cellular immune response to live viral vaccines. Immunization with live vaccines may be considered in selected CHH patients with no or clinically mild immunodeficiency.

Citing Articles

Shorter birth length and decreased T-cell production and function predict severe infections in children with non-severe combined immunodeficiency cartilage-hair hypoplasia.

Pello E, Kainulainen L, Vakkilainen M, Klemetti P, Taskinen M, Makitie O J Allergy Clin Immunol Glob. 2024; 3(1):100190.

PMID: 38187867 PMC: 10770609. DOI: 10.1016/j.jacig.2023.100190.

Child type 1 diabetes associated with mother vaginal bacteriome and mycobiome.

Ruotsalainen A, Tejesvi M, Vanni P, Suokas M, Tossavainen P, Pirttila A Med Microbiol Immunol. 2022; 211(4):185-194.

PMID: 35701558 PMC: 9304052. DOI: 10.1007/s00430-022-00741-w.

Physician vaccination practices in mild to moderate inborn errors of immunity and retrospective review of vaccine completeness in IEI: results from the Canadian Immunization Research Network.

Suresh S, Zafack J, Pham-Huy A, Derfalvi B, Sadarangani M, McConnell A Allergy Asthma Clin Immunol. 2022; 18(1):32.

PMID: 35397595 PMC: 8994318. DOI: 10.1186/s13223-022-00667-1.

Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections.

Hetemaki I, Laakso S, Valimaa H, Kleino I, Kekalainen E, Makitie O Clin Immunol. 2021; 231:108851.

PMID: 34508889 PMC: 8425955. DOI: 10.1016/j.clim.2021.108851.

References

Otani N, Baba K, Okuno T . Interferon-gamma release assay: a simple method for detection of varicella-zoster virus-specific cell-mediated immunity. J Immunol Methods. 2009; 351(1-2):71-4. DOI: 10.1016/j.jim.2009.09.010. View

Saulsbury F, Winkelstein J, Davis L, Hsu S, DSouza B, Gutcher G . Combined immunodeficiency and vaccine-related poliomyelitis in a child with cartilage-hair hypoplasia. J Pediatr. 1975; 86(6):868-72. DOI: 10.1016/s0022-3476(75)80216-2. View

Thiel C, Horn D, Zabel B, Ekici A, Salinas K, Gebhart E . Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator. Am J Hum Genet. 2005; 77(5):795-806. PMC: 1271388. DOI: 10.1086/497708. View

Horn J, Schlesier M, Warnatz K, Prasse A, Superti-Furga A, Peter H . Fatal adult-onset antibody deficiency syndrome in a patient with cartilage hair hypoplasia. Hum Immunol. 2010; 71(9):916-9. DOI: 10.1016/j.humimm.2010.06.002. View

Ip W, Gaspar H, Kleta R, Chanudet E, Bacchelli C, Pitts A . Variable phenotype of severe immunodeficiencies associated with RMRP gene mutations. J Clin Immunol. 2015; 35(2):147-57. DOI: 10.1007/s10875-015-0135-7. View

Vakkilainen S, Taskinen M, Klemetti P, Pukkala E, Makitie O . A 30-Year Prospective Follow-Up Study Reveals Risk Factors for Early Death in Cartilage-Hair Hypoplasia. Front Immunol. 2019; 10:1581. PMC: 6646460. DOI: 10.3389/fimmu.2019.01581. View

Kennedy R, Ovsyannikova I, Thomas A, Larrabee B, Rubin S, Poland G . Differential durability of immune responses to measles and mumps following MMR vaccination. Vaccine. 2019; 37(13):1775-1784. PMC: 6414234. DOI: 10.1016/j.vaccine.2019.02.030. View

Harrington W, Mato S, Burroughs L, Carpenter P, Gershon A, Schmid D . Vaccine Oka Varicella Meningitis in Two Adolescents. Pediatrics. 2019; 144(6). PMC: 6889945. DOI: 10.1542/peds.2019-1522. View

Ridanpaa M, van Eenennaam H, Pelin K, Chadwick R, JOHNSON C, Yuan B . Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell. 2001; 104(2):195-203. DOI: 10.1016/s0092-8674(01)00205-7. View

10.

Vatanavicharn N, Visitsunthorn N, Pho-iam T, Jirapongsananuruk O, Pacharn P, Chokephaibulkit K . An infant with cartilage-hair hypoplasia due to a novel homozygous mutation in the promoter region of the RMRP gene associated with chondrodysplasia and severe immunodeficiency. J Appl Genet. 2010; 51(4):523-8. DOI: 10.1007/BF03208884. View

11.

Makitie O, Kaitila I . Cartilage-hair hypoplasia--clinical manifestations in 108 Finnish patients. Eur J Pediatr. 1993; 152(3):211-7. DOI: 10.1007/BF01956147. View

12.

Smith J, Liu X, Kaufhold R, Clair J, Caulfield M . Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus. Clin Diagn Lab Immunol. 2001; 8(5):871-9. PMC: 96163. DOI: 10.1128/CDLI.8.5.871-879.2001. View

13.

MCKUSICK V, Eldridge R, Hostetler J, RUANGWIT U, Egeland J . DWARFISM IN THE AMISH. II. CARTILAGE-HAIR HYPOPLASIA. Bull Johns Hopkins Hosp. 1965; 116:285-326. View

14.

Bacchetta J, Ranchin B, Brunet A, Bouvier R, Duquesne A, Edery P . Autoimmune hypoparathyroidism in a 12-year-old girl with McKusick cartilage hair hypoplasia. Pediatr Nephrol. 2009; 24(12):2449-53. DOI: 10.1007/s00467-009-1256-0. View

15.

Kreth H, Lee B, Kosuwon P, Salazar J, Gloriani-Barzaga N, Bock H . Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix). BioDrugs. 2008; 22(6):387-402. DOI: 10.2165/0063030-200822060-00005. View

16.

Michalik D, Steinberg S, LaRussa P, Edwards K, Wright P, Arvin A . Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis. 2008; 197(7):944-9. PMC: 2657090. DOI: 10.1086/529043. View

17.

Kostjukovits S, Degerman S, Pekkinen M, Klemetti P, Landfors M, Roos G . Decreased telomere length in children with cartilage-hair hypoplasia. J Med Genet. 2016; 54(5):365-370. DOI: 10.1136/jmedgenet-2016-104279. View

18.

Buchbinder D, Hauck F, Albert M, Rack A, Bakhtiar S, Shcherbina A . Rubella Virus-Associated Cutaneous Granulomatous Disease: a Unique Complication in Immune-Deficient Patients, Not Limited to DNA Repair Disorders. J Clin Immunol. 2019; 39(1):81-89. PMC: 7739844. DOI: 10.1007/s10875-018-0581-0. View

19.

Sobh A, Bonilla F . Vaccination in Primary Immunodeficiency Disorders. J Allergy Clin Immunol Pract. 2016; 4(6):1066-1075. DOI: 10.1016/j.jaip.2016.09.012. View

20.

Lux S, JOHNSTON Jr R, August C, Say B, Penchaszadeh V, Rosen F . Chronic neutropenia and abnormal cellular immunity in cartilage-hair hypoplasia. N Engl J Med. 1970; 282(5):231-6. DOI: 10.1056/NEJM197001292820501. View